In the cardiovascular system, a comprehensive bioinformatics analysis of genes and miRNAs was performed to elucidate which factors may be involved in the progression of cardiac hypertrophy, demonstrating that miR-448 has a regulatory effect on differentially expressed SIM2 in TAC-induced hypertrophy [29]. The gene discussed is SIM2; the disease is cardiac hypertrophy.